Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. BridgeBio Pharma’s experimental drug for the ...
Get ready to take your business development strategy from the boardroom to the beach at the BIO Investment & Growth Summit, happening March 2–3, 2026, in sunny Miami Beach! Before you pack your ...
MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of ...
Successfully started 216 patients on IBTROZI ® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient starts since launch in the second half of June 2025 Preliminary IBTROZI net ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Medical biotechnology company ...
SINGAPORE—Aisheng Technology Group, a subsidiary of China’s state-owned arms producer Norinco, carried out the first flight of the Tian Ma TM-1000 large cargo uncrewed aircraft system (UAS) on Jan. 11 ...
The first terrorist acts against the leaders of the newly established Soviet government were carried out on August 30, 1918, by Jews Leonid Kannegiesser and Fanny Kaplan. Kannegiesser killed the ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. So, you’ve got a case of the dreaded “winter ...
The book took only 12 years to write. “Our wives couldn’t understand why we didn’t wrap this thing up in a couple of days,” said Bobby Rich, retired legendary radio on-air personality, programmer and ...
Electrical towers above Altadena on Feb. 8, 2025. Biomass energy is electricity made by burning or gasifying trees. Photo by Jules Hotz for CalMatters Welcome to CalMatters, the only nonprofit ...
Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results